Ianalumab (Anti-TNFRSF13C / BAFFR / CD268)

Synonyms: VAY-736

Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) is a fully human combinatorial antibody library (HuCAL)-derived monoclonal antibody targeting the B-cell-activating factor receptor (BAFF-R), with potential anti-inflammatory and antineoplastic activities. MW : 145.5 KD.

Ianalumab (Anti-TNFRSF13C / BAFFR / CD268)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) is a fully human combinatorial antibody library (HuCAL)-derived monoclonal antibody targeting the B-cell-activating factor receptor (BAFF-R), with potential anti-inflammatory and antineoplastic activities. MW : 145.5 KD.

Product Details

CAS No. 1929549-92-7
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) | Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) supplier | purchase Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) | Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) cost | Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) manufacturer | order Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) | Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) distributor